MYCOPHENOLATE MOFETIL VS CYCLOPHOSPHAMIDE IN SCLERODERMA ASSOCIATED INTERSTITIAL LUNG DISEASE(ILD) - SINGLE CENTER OBSERVATIONAL STUDY

被引：0
作者：
Bavaliya, M. [1 ]
Padmanabha, S. [1 ]
机构：
[1] Amrita Inst Med Scienece, Kochi, Kerala, India
来源：
INTERNAL MEDICINE JOURNAL | 2015年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARP85
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [31] COMPARISON OF LONG-TERM CYCLOPHOSPHAMIDE (CY) AND MYCOPHENOLATE MOFETIL (MMF) EFFICACY AND SAFETY IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) AND INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ovsyannikova, O.
    Desiniva, O.
    Garzanova, L.
    Ananieva, L.
    Starovoytova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1108 - 1109
  • [32] Effects Of Mycophenolate Mofetil In Connective Tissue Disease-Associated Interstitial Lung Disease
    Takada, T.
    Asakawa, K.
    Sakagami, T.
    Moriyama, H.
    Narita, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [33] Efficacy of Mycophenolate Mofetil in the Treatment of Rheumatoid Arthritis Associated Interstitial Lung Disease
    Amos, Jonathan
    Kendall, Jennifer
    Moran, Robyn
    Krause, Megan
    Schmidt, Paul
    Hall, Chase
    Hamblin, Mark
    Maz, Mehrdad
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] Efficacy of Rituximab for Connective Tissue Disease (CTD) Associated Interstitial Lung Disease (ILD) : A Single Center Study of 47 PatientsExtension Study
    Qurie, Ahmad
    Maruvada, Smita
    Umer, Sarwat
    Mclarty, Jerry
    Hayat, Samina
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [35] Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease
    Fischer, Aryeh
    Brown, Kevin K.
    Du Bois, Roland M.
    Frankel, Stephen K.
    Cosgrove, Gregory P.
    Fernandez-Perez, Evans R.
    Huie, Tristan J.
    Krishnamoorthy, Mahalakshmi
    Meehan, Richard T.
    Olson, Amy L.
    Solomon, Joshua J.
    Swigris, Jeffrey J.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (05) : 640 - 646
  • [36] Efficacy of Rituximab for Connective Tissue Disease (CTD) Associated Interstitial Lung Disease (ILD): a Single Center Study of 47 Patients
    Tariq, Madiha
    Patel, Sunny
    Umer, Sarwat
    Caldito, Gloria
    Hayat, Samina
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [37] Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
    Wang, Pengfei
    Zhang, Li
    Guo, Qian
    Zhao, Lifen
    Hao, Yanyan
    OPEN MEDICINE, 2023, 18 (01):
  • [38] Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study
    Owen, C.
    Ngian, G-S.
    Elford, K.
    Moore, O.
    Stevens, W.
    Nikpour, M.
    Rabusa, C.
    Proudman, S.
    Roddy, J.
    Zochling, J.
    Hill, C.
    Sturgess, A.
    Tymms, K.
    Youssef, P.
    Sahhar, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (05) : S170 - S176
  • [39] Combination Therapy of Mycophenolate Mofetil and Pirfenidone vs. Mycophenolate Alone: Results from the Scleroderma Lung Study III
    Khanna, Dinesh
    Spino, Cathie
    Bernstein, Elana
    Goldin, Jonathan
    Tashkin, Donald
    Roth, Michael
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1045 - 1047
  • [40] Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease
    Konstantinos Gkiouras
    Maria G. Grammatikopoulou
    Theodora Simopoulou
    Zoe Daniil
    Dimitrios P. Bogdanos
    Clinical Rheumatology, 2021, 40 : 3379 - 3380
12345